Open an account

Morgan Stanley

MS · NYSE

$180.40+$1.93 (+1.08%)TodayMarket closed ·
Prev close $178.47

About MS

Morgan Stanley operates as a global financial services company. The company is headquartered in New York City, New York and currently employs 83,922 full-time employees. The firm is engaged in providing a range of investment banking, securities, wealth management and investment management services. Its segments include Institutional Securities, Wealth Management and Investment Management. Its Institutional Securities segment provides a variety of products and services to corporations, governments, financial institutions and ultra-high net worth clients. Its Wealth Management segment provides an array of financial services and solutions to individual investors and small to medium-sized businesses and institutions. Its Investment Management segment provides a range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Its investment banking services consist of capital raising and financial advisory services, including the underwriting of debt and other products.

Employees
83,922
Headquarters
New York City, New York
Listed
Mar 21, 1986
Sector
Financials
Industry
Capital Markets
Website
morganstanley.com

MS key statistics

Market cap
280.30B
Price-earnings ratio
14.43
Dividend yield
2.39%
Average volume
5.99M
Volume
3.60M
Open price
$177.52
High today
$182.89
Low today
$176.74
52 Week high
$232.25
52 Week low
$152.80

Morgan Stanley (MS) at a glance

As of Oct 20, 2026, Morgan Stanley (MS) shares are priced at $180.40, giving the company a market cap of 280.30B, a price-to-earnings ratio of 14.43 and a dividend yield of 2.39%.

Today the stock has traded between $176.74 and $182.89. The current price is 2.1% above the day's low and 1.4% below its high.

Volume so far is 3.60M shares, below the average of 5.99M shares a day.

Over the past year Morgan Stanley has ranged from $152.80 to $232.25, and now sits 35% of the way up that range.

Morgan Stanley met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q3 FY26 it reported $3.03 per share against an estimate of $3.00.

The average analyst price target is $242.65, 34.5% above the current price, from 19 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

42%of 19 analyst ratings say Buy
  • Buy42.1%
  • Hold52.6%
  • Sell5.3%
Price target · 23 analystsAvg $242.65
Low
$200.99
Now
$180.40
High
$275.10

MS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 13.7% on average.

  1. Q4 FY24: reported $2.22 per share against an estimate of $1.75
  2. Q1 FY25: reported $2.60 per share against an estimate of $2.27
  3. Q2 FY25: reported $2.13 per share against an estimate of $2.01
  4. Q3 FY25: reported $2.80 per share against an estimate of $2.17
  5. Q4 FY25: reported $2.68 per share against an estimate of $2.51
  6. Q1 FY26: reported $3.43 per share against an estimate of $3.09
  7. Q2 FY26: reported $3.46 per share against an estimate of $3.03
  8. Q3 FY26: reported $3.03 per share against an estimate of $3.00

MS news

  • Daragh Thomas

    Morgan Stanley's Mike Wilson Says Market Correction Nearly Over, Sees S&P 500 Hitting 8,500

  • Press releaseBusiness Wire

    Morgan Stanley Survey: 401(k) Plans Rival Healthcare as Top Valued Benefit

  • Piero Cingari

    Bank Stocks Are On Their Longest Losing Streak Since 2008: Rates Aren't The Only Problem

  • Press releaseBusiness Wire

    Morgan Stanley Capital Partners Acquires The Rapid Group

  • Press releasePRNewswire

    U.S. Adds 440,000 Millionaires in 2025 as Wealth Hits Record Highs OR Driven by the Stock Market, U.S. Minting Millionaires at Record Pace

  • Press releasePRNewswire

    /R E I S S U E - Market Updates/

  • Mohd Haider

    Billionaire Investor Dan Loeb’s Third Point Bought Stakes in Two Food Distributors in One Quarter — Here’s What’s Happening at Both

  • Mohd Haider

    Recursion Pharmaceuticals (RXRX) Stock is Trending After Hours: Here’s What You Should Know

Similar companies

Companies in the same industry as Morgan Stanley

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.